5‑Amino‑1MQ is a synthetic small molecule inhibitor specifically designed to block the activity of Nicotinamide N‑Methyltransferase (NNMT) — an enzyme involved in methylation metabolism and energy homeostasis. NNMT catalyzes the methylation of nicotinamide using S‑adenosyl‑methionine (SAM), and elevated NNMT activity has been associated with metabolic dysfunction, insulin resistance, obesity, and age‑related metabolic decline in various research models. By inhibiting NNMT, 5‑Amino‑1MQ is widely used in laboratory studies investigating metabolic regulation, adipocyte biology, glucose homeostasis, and epigenetic methylation pathways.
In research settings, 5‑Amino‑1MQ is typically supplied as a white to off‑white powder that can be dissolved in appropriate solvents (e.g., DMSO, PBS) depending on the experimental protocol. It is used in in‑vitro assays, cell culture models, and preclinical research to study how NNMT inhibition affects cellular metabolism, lipid utilization, gene regulation, and related biochemical pathways.
High research quality is ensured by analytical verification of purity and identity, and the compound is usually manufactured with high chemical purity suitable for reproducible laboratory results. Proper storage and handling are required to preserve its integrity for experimental use.
A Certificate of Analysis (COA) is typically provided with each batch of 5‑Amino‑1MQ. The COA confirms important quality parameters such as purity percentage, chemical identity, molecular weight confirmation, and recommended storage conditions, along with batch/lot information for traceability and quality assurance.
5‑Amino‑1MQ is intended strictly for laboratory research use and is not FDA‑approved for human or clinical use. It is commonly employed in research on metabolic pathways, enzyme inhibition studies, and energy regulation mechanisms.
